Auto Draft

Neurona Therapeutics Receives IND Clearance to Initiate Phase 1/2 Clinical Trial of Neural Cell Therapy NRTX-1001 in Chronic Focal Epilepsy Patients

November 04, 2021 08:00 ET | Source: Neurona Therapeutics SAN FRANCISCO, Nov. 04, 2021 (GLOBE NEWSWIRE) — Neurona Therapeutics, a biotherapeutics company advancing restorative neural cell therapies for the treatment of chronic neurological disorders, today...

Riccardo Gottardi, PhD

Assistant Professor, Pediatrics; Assistant Professor, Bioengineering, University of Pennsylvania Dr. Riccardo Gottardi is an Assistant Professor of Pediatrics and of Bioengineering at University of Pennsylvania. Dr. Gottardi leads the Bioengineering and Biomaterials...
FDA Approves Study to Investigate the Use of Cell Therapy to Treat COVID-19 Related Multisystem Inflammatory Syndrome in Children (MIS-C)

FDA Approves Study to Investigate the Use of Cell Therapy to Treat COVID-19 Related Multisystem Inflammatory Syndrome in Children (MIS-C)

First-of-its kind study to be supported by the Cura Foundation, The Marcus Foundation, Sanford Health and Alliance for Cell Therapy Now NEW YORK, Sept. 16, 2020 /PRNewswire/ — The Cura Foundation in collaboration with The Marcus Foundation, Sanford Health and...